NAFDAC says it has delisted 101 drugs from circulation in Nigeria. Action follows voluntary withdrawal requests and agency-initiated suspensions and cancellations Products affected include Flagyl, Artemether/Lumefantrine, insulin injectables, and eye drops The National Agency for Food and Drug Administration and Control (NAFDAC) has officially delisted 101 drugs from circulation across Nigeria. The announcement was made in a statement on Tuesday, specifying that the affected products are no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale, or use in the country. Reason for Delisting According to the agency, the action follows both voluntary withdrawal requests by market authorization holders and regulatory suspensions or cancellations initiated by NAFDAC. “A suspension applies when the conditions under which a registration licence was issued are no longer met, while a cancellation occurs when NAFDAC revokes a product’s licence,” the statement said. READ ALSO: NAFDAC Bans Petroleum Tankers from Transporting Cooking Oil Drugs Affected The delisted products cover a wide range of treatments, including: Antimalarials: Artemether/Lumefantrine, ASAQ (Artesunate-Amodiaquine) formulations Antibiotics: Flagyl suspension and tablets, Penicillin G Sodium Sandoz powder Diabetes medications: Januvia, Janumet Vaccines: Cryomarex Rispens HVT Injectables: Norditropin growth hormone, insulin Others: Betopic and Elisca eye drops, inhalers, and cough treatments The agency clarified that a product’s certificate of registration is considered withdrawn when the Market Authorization Holder requests its discontinuation. “This is to inform the General Public that the following products are approved for withdrawal, suspension, and cancellation by NAFDAC. They are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale, and use within Nigeria,” the statement read. Impact on Public NAFDAC urged consumers and healthcare providers to immediately stop using or selling the affected products and verify alternatives with licensed suppliers. For publication of Press Releases, Statements, and Advert Inquiries, send an email to info@dailyreport.ng More On: 101 Drugs, NAFDAC
